BASF increases prices for pharmaceutical excipients and active ingredients

05-Apr-2011 - Germany

Effective April 1, 2011, BASF will increase the sales prices globally for all pharmaceutical excipients and active pharmaceuticals ingredients by at least 10% depending on the product group.

This price increase affects the entire excipients portfolio including the Kollidon®, Kollicoat®, Cremophor®, and Lutrol® brands. The affected active pharmaceutical ingredient (API) portfolio contains products like Ibuprofen, Caffeine, and Ephedrine.

Due to the continued rise in costs for raw materials, energy and labor this price increase has become necessary. All existing contractual obligations will be honored.

Other news from the department price development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances